Atossa Therapeutics Statistics
Share Statistics
Atossa Therapeutics has 125.80M shares outstanding. The number of shares has increased by 0.4% in one year.
| Shares Outstanding | 125.80M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.03% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 125.75M |
| Failed to Deliver (FTD) Shares | 1.45K |
| FTD / Avg. Volume | 0.19% |
Short Selling Information
The latest short interest is 8.20M, so 6.52% of the outstanding shares have been sold short.
| Short Interest | 8.20M |
| Short % of Shares Out | 6.52% |
| Short % of Float | 6.52% |
| Short Ratio (days to cover) | 9.08 |
Valuation Ratios
The PE ratio is -3.69 and the forward PE ratio is -5.56.
| PE Ratio | -3.69 |
| Forward PE | -5.56 |
| PS Ratio | 0 |
| Forward PS | 2.3 |
| PB Ratio | 1.22 |
| P/FCF Ratio | -5294.74 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Atossa Therapeutics Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.61, with a Debt / Equity ratio of 0.
| Current Ratio | 17.61 |
| Quick Ratio | 17.33 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.33% and return on capital (ROIC) is -34.47%.
| Return on Equity (ROE) | -0.33% |
| Return on Assets (ROA) | -0.31% |
| Return on Capital (ROIC) | -34.47% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.51M |
| Employee Count | 12 |
| Asset Turnover | 0 |
| Inventory Turnover | 0.02 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 8.6% in the last 52 weeks. The beta is 1.23, so Atossa Therapeutics 's price volatility has been higher than the market average.
| Beta | 1.23 |
| 52-Week Price Change | 8.6% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.38 |
| Relative Strength Index (RSI) | 39.77 |
| Average Volume (20 Days) | 744.35K |
Income Statement
| Revenue | n/a |
| Gross Profit | -23.00K |
| Operating Income | -31.38M |
| Net Income | -30.09M |
| EBITDA | -31.35M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.24 |
Balance Sheet
The company has 88.46M in cash and 0 in debt, giving a net cash position of 88.46M.
| Cash & Cash Equivalents | 88.46M |
| Total Debt | 0 |
| Net Cash | 88.46M |
| Retained Earnings | -186.29M |
| Total Assets | 79.48M |
| Working Capital | 71.31M |
Cash Flow
In the last 12 months, operating cash flow was -20.94K and capital expenditures -14, giving a free cash flow of -20.95K.
| Operating Cash Flow | -20.94K |
| Capital Expenditures | -14 |
| Free Cash Flow | -20.95K |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -23.76% |
| FCF Yield | -0.02% |
Analyst Forecast
The average price target for ATOS is $7, which is 593.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 593.1% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Apr 20, 2018. It was a backward split with a ratio of 1:12.
| Last Split Date | Apr 20, 2018 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | 9.65 |
| Piotroski F-Score | 3 |